<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8804207</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1862</journal-id>
<journal-id journal-id-type="nlm-ta">Schizophr Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Schizophr. Res.</journal-id>
<journal-title-group>
<journal-title>Schizophrenia research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0920-9964</issn>
<issn pub-type="epub">1573-2509</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30594456</article-id>
<article-id pub-id-type="pmc">7321970</article-id>
<article-id pub-id-type="doi">10.1016/j.schres.2018.12.012</article-id>
<article-id pub-id-type="manuscript">NIHMS1069054</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rare variants in Protein tyrosine phosphatase, receptor type A (<italic>PTPRA</italic>) in schizophrenia: Evidence from a family based study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>John</surname>
<given-names>Jibin</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kukshal</surname>
<given-names>Prachi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Aditya</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhatia</surname>
<given-names>Triptish</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nimgaonkar</surname>
<given-names>V.L.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deshpande</surname>
<given-names>S.N.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thelma</surname>
<given-names>B.K.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi 110 021, India</aff>
<aff id="A2"><label>b</label>Department of Psychiatry, PGIMER-Dr. RML Hospital, New Delhi 110 001, India</aff>
<aff id="A3"><label>c</label>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, 3811 Oâ€™Hara Street, Pittsburgh, PA 15213, USA</aff>
<aff id="A4"><label>d</label>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, DeSoto St, Pittsburgh, PA 15213, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Contributions</p>
<p id="P2">Prof. B.K. Thelma, Prof. S. N. Deshpande and Prof. V. L. Nimgaonkar designed the study and obtained research funding; Prof. S. N. Deshpande diagnosed and recruited the study samples; Dr. Jibin John performed all the WES data analysis, interpretation, and confirmation of variants by Sanger sequencing and linkage analysis. Dr. Triptish Bhatia contributed to sample recruitment and phenotype data documentation; Dr. Prachi Kukshal maintained the DNA repository and contributed to data analysis and interpretation; Mr. Aditya Sharma contributed to data analysis; Jibin John, B.K. Thelma and V. L. Nimgaonkar wrote the first draft of manuscript; all authors contributed to and have approved the final manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label>Corresponding author, <email>thelmabk@gmail.com</email> (B.K. Thelma).</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P25">Conflict of interest</p>
<p id="P26">The authors declare that there are no conflicts of interest in relation to the subject of this study.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>206</volume>
<fpage>75</fpage>
<lpage>81</lpage>
<!--elocation-id from pubmed: 10.1016/j.schres.2018.12.012-->
<abstract id="ABS1">
<p id="P3">The contribution of both common and rare risk variants to the genetic architecture of schizophrenia (SZ) has been documented in genome-wide association studies, whole exome and whole genome sequencing approaches. As SZ is highly heritable and segregates in families, highly penetrant rare variants are more likely to be identified through analyses of multiply affected families. Further, much of the gene mapping studies in SZ have utilized individuals of Caucasian ancestry. Analysis of other ethnic groups may be informative. In this study, we aimed at identification of rare, penetrant risk variants utilizing whole exome sequencing (WES) in a three-generation Indian family with multiple members affected. Filtered data from WES, combined with <italic>in silico</italic> analyses revealed a novel heterozygous missense variant (NM_080841:c.1730C&gt;G:p.T577R; exon18) in Protein tyrosine phosphatase, receptor type A <italic>(PTPRA</italic> 20p13). The variant was located in an evolutionary conserved position and predicted to be damaging. Screening for variants in this gene in the WES data of an independent SZ cohort (<italic>n</italic> = 350) of matched ethnicity, identified five additional rare missense variants with MAF &lt; 0.003, which were also predicted to be damaging. In conclusion, the rare missense variants in <italic>PTPRA</italic> identified in this study could confer risk for SZ. This has also derived support from concordant data from prior linkage and association, as well as animal studies which indicated a role for <italic>PTPRA</italic> in glutamate function.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>